Zusammenfassung
Kalzium gehört zu den wichtigsten Elementen des menschlichen Organismus. Es besitzt für viele Funktionen (Blutgerinnung, Muskelkontraktion u.v.a.m.) eine entscheidende Bedeutung und ist für die Statik des Knochens unverzichtbar. Aus diesen Gründen unterliegt die Regulation das Kalziumspiegels im Blut vielfältigen und feinen Regulationsmechanismen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aarskog D, Aksens L, Lehmann V (1980) Low 1, 25-dihydroxyvitamin D in heparin-induced osteopenia. Lancet ii: 650–651
Adinoff AD, Hollister JR (1983) Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309: 265–268
Aredia Breast Cancer Study Group (1996) Efficacy of Pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N Engl J Med 335: 1785–1791
Armbrecht HJ (1990) Effect of age on calcium and phosphate absorption: role of 1, 25-dihydroxy vitamin D. Miner Electrolyte Metab 16: 159–166
Aubin R, Menard P, Lajeunesse D (1996) Selective effect of thoazides on the human osteoblastlike cell line MG-63. Kidney Int 50: 1476–1482
Bardin CW, Swerdloff RS, Santen RJ (1991) Androgens: risks and benefits. J Clin Endocrinol Metab 73: 4–7
Baron DT, Teitelbaum SL, Bergfeld MA, Parker G, Cruvant EM, Aviolo EV (1980) Effect of alcohol ingestion on bone and mineral metabolism in rats. Am J Physiol 238: E507–E510
Basle MF, Mauras Y, Audran M, Clochon P, Rebel A, Allain P (1990) Concentration of bone elements in osteoporosis. J Bone Miner Res 5: 41–47
Baum HBA, Biller BMK, Finkelstein JS, Cannistraro KB, Oppenheim DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A (1996) Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. Ann Intern Med 125: 883–890
Benz DJ, Haussler MR, Thomas MA, Speelman B, Komm BS (1991) High-affinity androgen binding and androgenic regulation of alpha-1(I)-procollagen and transforming growth factorbeta steady-state messenger RNA levels in human osteoblast-like osteosarcoma cells. Endocrinology 128: 2723–2730
Binkle NC, Suttie JW (1995) Vitamin K nutrition and osteoporosis. J Nutr 125: 1812–1821
Boonen S, Lesaffre E, Dequeker J, Aerssens J, Nijs J, Pelemans W, Bouillon R (1996) Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years: potential implications for the prevention of age-related bone loss. J Am Geriatr Soc 44: 1301–1306
Bottermann P (1994) Moderne Behandlung der primären Osteoporose. Internist 35: 1105–1116
Briggs MH (1973) Cigarette smoking and infertility in men. Med J Austr 1: 616–617
Bröll H (1996) A clinical survey of osteoporosis. In: Bröll H, Dambacher MA (eds) Osteoporosis: a guide to diagnosis and treatment. Karger, Basel
Bronner F (1989) Renal calcium transport: mechanism and regulation. Am J Physiol 257: F707–F711
Brown JP, Malaval J, Chapuy MC, Delmas PD, Edouard D, Meunier PJ (1984) Serum bone GLA-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet ii: 1091–1093
Chapuy MC, Chapuy P, Meunier PJ (1987) Calcium and vitamin D supplements: effects on calcium metabolism in elderly people. Am J Clin Nutr 46: 324–328
Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327: 1637–1642
Colditz G, Hankinson S, Hunter J, Willett W, Manson J, Stampfer M, Hennekens C, Rosner B, Speizer F (1991) The use of oestrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332: 274–277
Compston JE (1992) Risk factors for osteoporosis. Clin Endocrinol 36: 223–224
Consensus Development Conference (1991) Conference Report: prophylaxis and treatment of osteporosis. Osteoporosis Int 1: 114–117
Dawson-Hughes B, Dallai GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S (1990) A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323: 878–883
Delmas PD (1996) Biphosphonates in the treatment of bone diseases. N Engl J Med 335: 1836–1837
Dempster DW, Lindsay R (1993) Pathogenesis of osteoporosis. Lancet 341: 797–801
Douglas AS, Robins SP, Hutchinson JD, Proter RW, Stewart A, Reid DM (1995) Carboxylation of osteocalcin in post-menopausal osteoporotic women following vitamin K and D supplementation. Bone 17: 15–20
Duursma SA, Slootweg MC, Bijlsma JWJ (1988) How does oestrogen prevent postmenopausal osteoporosis? In: Bergener M, Ermini M, Stähelin HB (eds) Crossroads in aging. Academic Press, New York
Duursma SA, Raymakers JA, Scheven BAA, Jansen PAF (1993) Osteoporosis. Rev Clin Gerontol 3: 135–146
Eastell R, Yergey AL, Vieira NE (1991) Interrelationship among vitamin D metabolism, true calcium absorption parathyroid function, and age in women: evidence of an age-related intestinal resistance to 1, 25-dihydroxyvitamin D action. J Bone Miner Res 6: 125–132
Eriksen EF, Mosekilde L, Meisen F (1985) Trabecular bone remodeling and bone balance in hyperthyroidism. Bone 6: 421–428
Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241: 84–86
Ernst M, Schmid C, Froesch ER (1988) Enhanced Osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci 85: 2307–2310
Farley JR, Wergedal JE, Baylink DJ (1983) Fluoride directly stimulates proliferation and alkaline Phosphatase activitiy of bone-forming cells. Science 227: 320–332
Finkelstein JS, Neer RM, Biller BMK, Crawford JD, Klibanski JA (1992) Osteopenia in men with a history of delayed puberty. N Engl J Med 326: 600–604
Gloth FM, Gundberg CM, Hollis BW, Haddad JG, Tobin JD (1995) Vitamin D deficiency in homebound elderly persons. J Am Med Assoc 274: 1683–1686
Goodman CE (1985) Osteoporosis: protective measures of nutrition and exercise. Geriatics 40/4: 59–70
Grey AB, Stapleton JP, Evans MC, Tatneil MA, Reid IR (1996) Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. Ann Intern Med 125: 360–368
Griffith GC, Nichols G, Asher JD, Flanagan B (1965) Heparin osteoporosis. J Am Med Assoc 193: 85–88
Grynpas MD, Cheng PT (1988) Fluoride reduces the rate of dissolution of bone. Bone Miner 5: 1–9
Hahn TJ, Halsstead LR, Baran DT (1981) Effects of short-term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab 42: 111–115
Heaney RP, Recker RR, Saville PD (1978) Menopausal changes in bone remodeling. J Lab Clin Chem 92: 964–970
Hock JM, Centrella M, Canalis E (1988) Insulinlike growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 122: 254–260
Hodgkinson A, Thompson T (1982) Measurement of the fasting urinary hydroxyproline: Creatinine ratio in normal adults and its variation with age and sex. J Clin Pathol 35: 807–811
Holick MF, Matsuoka LY, Wortsman J (1989) Age, vitamin D, and solar ultraviolet. Lancet ii: 1104–1105
Jensen J, Christiansen C, Rodbro P (1985) Cigarette smoking, serum estrogens and bone loss during hormone-replacement therapy early after menopause. N Engl J Med 313: 973–975
Jilka RL, Hangoc G, Girasole G, Passen G, Williams D, Abrams J, Broxmeyer H, Manolagas SC (1992) Increased osteoclast development after estrogen loss: mediation by Interleukin 6. Science 257: 88–91
Joborn C, Ljunghall S, Larsson K, Lindh E, Naessen T, Wide L, Akerström G, Rastaad J (1991) Skeletal responsiveness to parathyroid hormone in healthy females: relationship to menopause and oestrogen replacement. Clin Endocrinol 34: 335–339
Kanis JA, Johnell O, Gullberg B, Allander E, Dilsen G, Gennari C, Vaz AA, Lyritis GP, Mazzuoli G, Miravet L, Passen M, Cano RP, Rapado A, Ribot C (1992) Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. Br Med J 305: 1124–1128
Kannus P, Palvanen M, Niemi S, Parkkari J, Järvinen M, Vuori I (1996) Increasing number and incidience of osteoporotic fractures of the proximal humerus in elderly people. Br Med J 313: 1051–1052
Kannus P, Parkkari J, Niemi S (1995) Age-adjusted incidence of hip fracture. Lancet 346: 50–51
Karpf DB, Shapiro DR, Seeman E, Ensrud KE, Johnston CC, Adami S, Harris ST, Santora AC, Hirsch LJ, Oppenheimer L, Thompson D (1997) Prevention of nonvertebral fractures by alendronat. J Am Med Assoc 277: 1159–1164
Kasperk CH, Ziegler R (1992) Androgene und Knochenstoffwechsel. Dtsch Med Wochenschr 117: 990–996
Krexner E, Resch H, Pietschmann P, Bernecker P, Wolosczuk W, Vukovich Th, Geyer G, Willvonseder R (1996) Vitamin D status in residents of a long-term-care geriatric hospital in Vienna. Osteologie 5: 13–18
Krischker U, Frank A, Schröter T, Donath G (1994) Wertigkeit der Osteodensitometrie mittels peripheren quantitativen CT am distalen Radius zur Frühdiagnose der präklinischen Osteoporose. Prävent Rehab 6: 60–64
Kurokawa K (1996) How is plasma calcium held constant? Milieu interieur of calcium. Kidney Int 49: 1760–1764
Lewis AF (1981) Fracture of the neck of the femur: changing incidence. Br Med J 283: 1217–1220
Lindsay R, Nievers J (1994) Milk and bones. You are what you drink. Br Med J 308: 930–931
Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112: 352–364
Lyritis GP, Tsakalakos N, Magiasus B, Karachalios T, Yatzides A, Tsekoura M (1991) Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebocontrolled clinical study. Calcif Tissue Int 49: 369–372
Marie PJ, DeVernejoul MC, Lomri A (1992) A stimulation of bone formation in osteoporosis patients treated with flouride associated with increased DNA synthesis by osteoblastic cells in vitro. J Bone Miner Res 7: 103–113
McCarthy TL, Centrella M, Canalis E (1989) Regulatory effects of insulin-like growth factors I and II on bone collagene synthesis in rat calvarial cultures. Endocrinology 124: 301–309
Menon RK, Gill DS, Thomas M, Kernoff PB, Dandona P (1987) Impaired carboxylation of osteocalcin in warfarin-treated patients. J Clin Endocrinol Metab 64: 59–61
Moore EW (1970) Ionized calcium in normal serum, ultrafiltrates and whole blood determined by ion-exchange electrodes. J Clin Invest 39: 318–320
Mosekilde L (1996) Can we influence the degenerative diseases (osteoporosis and Osteoarthritis)? In: Viidik A, Hofecker G (eds) Vitality, mortality and ageing. Facultas, Wien
Murphy S, Khaw K-T, Prentice A, Compstone JE (1993) Relationship between parathyroid hormone, 25-hydroxyvitamin D, and bone mineral density in elderly men. Age Ageing 22: 198–204
Murphy S, Khaw KT, May H, Compton JE (1994) Milk consumption and bone mineral density in middle aged and elderly women. Br Med J 308: 939–941
Need AG, Durbridge TC, Nordin BEC (1993) Anabolic steroids in postmenopausal osteoporosis. Wien Med Wochenschr: 392-395
Nicolas V, Prewett A, Mohan S, Finkelman RD, Baylink DJ, Farley JR (1994) Age-related decreases in insulin-like growth factor-I and transforming growth factor-ß in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab 78: 1011–1016
Nordin BEC (1989) Calcium requirement and the menopause. Med J Aust 141: 114–119
Ott SM (1992) Estrogen therapy for osteoporosis. Even in the elderly. Ann Intern Med 117: 85–86
Pak CY, Sakhaee K, Piziak V, Peterson RD, Breslau NA, Boyd P (1994) Slow release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial. Ann Intern Med 120: 625–632
Persson I, Adami H, Bergkvist L (1989) Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. Br Med J 298: 147–151
Philip WJ, Martin JC, Richardson JM, Reid DM, Webster J, Douglas AS (1995) Decreased axial and peripheral bone density in patients taking long-term warfarin. Q J Med 88: 635–640
Prince RL, Smith M, Dick IM, Price RI, Webb PG, Henderson NK, Harris MM (1990) Prevention of postmenopausal osteoporosis: a comparative study of exercise, calcium supplementation, and hormone replacement therapy. N Engl J Med 325: 1189–1195
Reginster TY, Deroisy R, Albert A (1989) Relationship between whole plasma calcitonin levels, calcitonin secretion capacity, and plasma levels of estron in healthy women and postmenopausal osteoporotics. J Clin Invest 83: 1073–1077
Reginster JY (1991) Effect of calcitonin on bone mass and fracture rate. Am J Med 91: 19–22
Reid IR (1989) Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 30: 83–103
Riggs BL, Melton LJ (1986) Involutional osteoporosis. N Engl J Med 314: 1676–1684
Riggs BL, Hodgson SF, O’Fallou WM, Chao EYS, Wachner H, Muhs JM, Cedel SL, Melton JL (1990) Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 332: 802–809
Riggs BL, Melton LJ (1992) The prevention and treatment of osteoporosis. N Engl J Med 327: 620–627
Ringe JD, Kruse HP, Kuhlencordt F (1982) Natriumfluorid und Calzium zur Therapie der primären Osteoporose. Med Klin 77: 86–89
Resch A, Schneider B, Bernecker P, Battmann A, Wergedal J, Willvonseder R, Resch H (1995) Risk of vertebral fractures in men: relationship to mineral density of the vertebral body. Am J Radiol 164: 1447–1450
Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP (1981) Impaired growth hormone secretion in the adult population. J Clin Invest 67: 1361–1369
Rutherford OM, Jones DA (1992) The relationship of muscle and bone loss and activity levels with age in women. Age Ageing 21: 286–293
Scane AC, Francis RM (1993) Riskfactors for osteoporosis in men. Clin Endocrinol 38: 15–16
Schneider DL, Barrett-Connor EL, Morton DJ (1997) Timing of postmenopausal estrogen for optimal bone mineral density. J Am Med Assoc 277: 543–547
Sherman SS, Hollis BW, Tobin JD (1990) Vitamin D status and related parameters in a healthy population. The effects of age, sex and season. J Clin Endocrinol Metab 71: 405–413
Smith R (1996) Investigation of osteoporosis. Clin Endocrinol 44: 371–374
Smith R (1993) Molecular, cellular and metabolic mechanisms of osteoporosis. Rev Clin Gerontol 3: 107–116
Stampfer MJ, Colditz GA (1988) Estrogen replacement therapy and coronary heart disease, a quantitative assessment of the epidemiologic evidence. Prev Med 17: 201–223
Storm T, Thamsborg G, Steiniche T, Genant HK, Soerensen OH (1990) Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322: 1265–1271
Wasnich R, Davis J, Ross P, Vogel J (1990) Effect of thiazide on rates of bone mineral loss: a longitudinal study. Br Med J 301: 1303–1305
Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson GC, Yanover MJ, Mysinde WJ, Kohre L, Rao MB, Steiger P, Richmond B, Chesmont CH (1990) Intermittend cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323: 73–79
Weinstein RS, Bryce GF, Sappington LJ, King DW, Gallagher BB (1984) Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug therapy. J Clin Endocrinol Metab 58: 1003–1009
Wilson RJ, Rao DS, Ellis B, Kleerekoper M, Parfitt AM (1988) Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 109: 959–962
Wingo P, Lee N, Ory H, Beral V, Peterson H, Rhodes P (1993) Age specific differences in the relationship between oral contraceptive use and breast cancer. Cancer 71/4: 1506–1517
Writing Group for the PEPI Trial (1996) Effects of hormone therapy on bone mineral density. J Am Med Assoc 276: 1389–1396
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Wien
About this chapter
Cite this chapter
Tragl, K.H. (1999). Knochenstoffwechsel und Osteoporose. In: Handbuch der Internistischen Geriatrie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6409-9_13
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6409-9_13
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7317-6
Online ISBN: 978-3-7091-6409-9
eBook Packages: Springer Book Archive